LYEL fundamentals

An in-depth look to Lyell Immunopharma, Inc. operating, investing, and financing activities

LYEL free cash flow for Q4 24 is -47.29 M USD. For 2024, LYEL free cash flow was -162.86 M USD and operating cash flow was -162.39 M USD.

Q1 '20

Q2 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD